IL137458A0 - Genetic immunization with nonstructural proteins of hepatitis c virus - Google Patents
Genetic immunization with nonstructural proteins of hepatitis c virusInfo
- Publication number
- IL137458A0 IL137458A0 IL13745899A IL13745899A IL137458A0 IL 137458 A0 IL137458 A0 IL 137458A0 IL 13745899 A IL13745899 A IL 13745899A IL 13745899 A IL13745899 A IL 13745899A IL 137458 A0 IL137458 A0 IL 137458A0
- Authority
- IL
- Israel
- Prior art keywords
- hepatitis
- virus
- nonstructural proteins
- genetic immunization
- immunization
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
- 230000002068 genetic effect Effects 0.000 title 1
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7315698P | 1998-01-30 | 1998-01-30 | |
| PCT/US1999/001823 WO1999038880A1 (en) | 1998-01-30 | 1999-01-28 | Genetic immunization with nonstructural proteins of hepatitis c virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL137458A0 true IL137458A0 (en) | 2001-07-24 |
Family
ID=22112053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13745899A IL137458A0 (en) | 1998-01-30 | 1999-01-28 | Genetic immunization with nonstructural proteins of hepatitis c virus |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1056762A4 (en) |
| JP (1) | JP2002501737A (en) |
| KR (2) | KR100628411B1 (en) |
| CN (3) | CN101126094A (en) |
| AU (1) | AU746258B2 (en) |
| BR (1) | BR9908540A (en) |
| CA (1) | CA2318744A1 (en) |
| IL (1) | IL137458A0 (en) |
| WO (1) | WO1999038880A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2411096T3 (en) * | 1999-10-27 | 2013-07-04 | Novartis Vaccines And Diagnostics, Inc. | Activation of specific T lymphocytes against HCV |
| CN1425027A (en) * | 1999-11-24 | 2003-06-18 | 希龙公司 | HCV non-structural polypeptide |
| US6986892B1 (en) | 1999-11-24 | 2006-01-17 | Chiron Corporation | Immunogenic Hepatitis C virus non-structural polypeptides |
| JP4475561B2 (en) | 2001-10-11 | 2010-06-09 | メルク・シャープ・エンド・ドーム・コーポレイション | Hepatitis C virus vaccine |
| FR2855758B1 (en) | 2003-06-05 | 2005-07-22 | Biomerieux Sa | COMPOSITION COMPRISING NS3 / NS4 POLYPROTEIN AND HCV NS5B POLYPEPTIDE, EXPRESSION VECTORS INCLUDING THE CORRESPONDING NUCLEIC SEQUENCES AND THEIR USE IN THERAPEUTICS |
| KR101913674B1 (en) * | 2011-10-24 | 2018-10-31 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Improved hcv vaccines and methods for using the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE270326T1 (en) * | 1990-04-04 | 2004-07-15 | Chiron Corp | PROTEASE OF HEPATITIS C VIRUS |
| US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| ATE302854T1 (en) * | 1993-01-26 | 2005-09-15 | Univ Pennsylvania | COMPOSITIONS AND METHODS FOR ADMINISTRATION OF GENETIC MATERIAL |
| AU5924396A (en) * | 1995-05-22 | 1996-12-11 | Bionova Corporation | Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv) |
| ATE311463T1 (en) * | 1996-05-24 | 2005-12-15 | Chiron Corp | FUSION PROTEIN WITH MULTIPLE EPITOPES |
| JP2002500502A (en) * | 1996-06-11 | 2002-01-08 | メルク エンド カンパニー インコーポレーテッド | Synthetic hepatitis C gene |
| US6228576B1 (en) * | 1997-12-11 | 2001-05-08 | Smithkline Beecham Corporation | Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds |
-
1999
- 1999-01-28 CN CNA2007101384653A patent/CN101126094A/en active Pending
- 1999-01-28 WO PCT/US1999/001823 patent/WO1999038880A1/en not_active Application Discontinuation
- 1999-01-28 BR BR9908540-2A patent/BR9908540A/en not_active Application Discontinuation
- 1999-01-28 CN CNA2007101398938A patent/CN101126095A/en active Pending
- 1999-01-28 CA CA002318744A patent/CA2318744A1/en not_active Abandoned
- 1999-01-28 KR KR1020007008307A patent/KR100628411B1/en not_active IP Right Cessation
- 1999-01-28 AU AU24786/99A patent/AU746258B2/en not_active Ceased
- 1999-01-28 EP EP99904381A patent/EP1056762A4/en not_active Withdrawn
- 1999-01-28 IL IL13745899A patent/IL137458A0/en unknown
- 1999-01-28 CN CNB998024813A patent/CN100335637C/en not_active Expired - Fee Related
- 1999-01-28 KR KR1020067008960A patent/KR20060057653A/en not_active IP Right Cessation
- 1999-01-28 JP JP2000529347A patent/JP2002501737A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2318744A1 (en) | 1999-08-05 |
| CN101126094A (en) | 2008-02-20 |
| BR9908540A (en) | 2000-11-28 |
| KR20060057653A (en) | 2006-05-26 |
| AU746258B2 (en) | 2002-04-18 |
| WO1999038880A1 (en) | 1999-08-05 |
| KR20010086226A (en) | 2001-09-10 |
| KR100628411B1 (en) | 2006-09-28 |
| CN100335637C (en) | 2007-09-05 |
| EP1056762A4 (en) | 2003-07-23 |
| AU2478699A (en) | 1999-08-16 |
| EP1056762A1 (en) | 2000-12-06 |
| CN101126095A (en) | 2008-02-20 |
| CN1289339A (en) | 2001-03-28 |
| JP2002501737A (en) | 2002-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL324906A1 (en) | Vaccines against viral hepatitis of c type | |
| IL131688A0 (en) | Functional dna clone for hepatitis c virus (hcv) and uses thereof | |
| DE60014345D1 (en) | Makrozyklische peptide als hepatitis c virus ns3 protease inhibitore | |
| AU2055301A (en) | Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease | |
| AP2001002301A0 (en) | Inhibition of viral infection using monovalentantigen-binding proteins | |
| AU5285899A (en) | Anti hepatitis c virus antibody and uses thereof | |
| AU6371900A (en) | Lactam inhibitors of hepatitis c virus ns3 protease | |
| ZA9811316B (en) | Novel hepatitis C virus NS5B protein | |
| EP1627917A4 (en) | NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO | |
| ZA985762B (en) | Screening methods using an atpase protein from a virus of the flaviviridae family | |
| AU3714499A (en) | Hepatitis c virus mimotopes | |
| AU7602800A (en) | Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof | |
| HK1062579A1 (en) | A fusion protein for treatment of hepatitis b virus and its use thereof | |
| EP1141255A4 (en) | Modified forms of hepatitis c virus ns3 protease | |
| AU2001246331A1 (en) | Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof | |
| EP0747482A3 (en) | Hepatitis GB virus recombinant proteins and uses thereof | |
| IL137458A0 (en) | Genetic immunization with nonstructural proteins of hepatitis c virus | |
| EP1100545A4 (en) | Regulated expression of recombinant proteins using rna viruses | |
| EP1591524A4 (en) | Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus | |
| IL138804A0 (en) | Hepatitis c virus ns5b nucleic acids and proteins | |
| EP1113777A4 (en) | Novel hepatitis c virus peptides and uses thereof | |
| AU9494998A (en) | (in vivo), animal model for expression of hepatitis c virus | |
| IL116118A0 (en) | Papaya ringspot virus coat protein gene | |
| ZA964094B (en) | Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv) | |
| EP1521849A4 (en) | Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |